Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;91(1086):20170830.
doi: 10.1259/bjr.20170830. Epub 2018 Apr 9.

Tumor stiffness measured by quantitative and qualitative shear wave elastography of breast cancer

Affiliations

Tumor stiffness measured by quantitative and qualitative shear wave elastography of breast cancer

Eun Jee Song et al. Br J Radiol. 2018 Jun.

Abstract

Objective: To correlate clinicoradiologic and pathological features of breast cancer with quantitative and qualitative shear wave elastographic parameters.

Methods: 82 breast cancers in 75 patients examined by B-mode ultrasound and shear wave elastography (SWE) were included. SWE parameters including quantitative factors [maximum elasticity (Emax), mean elasticity (Emean), elasticity ratio (Eratio) and standard deviation (SD)] and qualitative factor (color pattern) were correlated with clinicoradiologic and pathological features using univariate and multivariate linear regression analyses.

Results: Presence of symptoms and larger tumor size on ultrasound were significantly associated with higher Emax, Emean, Eratio, and SD (all p < 0.05) on univariate analysis. Older age was significantly correlated with higher Emax and Emean (p = 0.026, 0.018). Lymphovascular invasion and larger pathologic size were significantly associated with higher Emax (p = 0.036, 0.043) and SD (p < 0.001, 0.019). No immunohistochemical biomarkers were significantly correlated with SWE parameters. There was no significant correlation between color pattern and any variable. Multivariate logistic regression analysis showed that the symptom, tumor size on ultrasound and lymphovascular invasion were independent factors that influenced the SWE values.

Conclusion: Tumor stiffness as measured by SWE and B-mode ultrasound could help predict cancer prognosis. Advances in knowledge: Clinicoradiologic factors had correlation with quantitative and qualitative SWE parameters. Using SWE parameters and B-mode ultrasound, we can predict breast cancer prognosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A 75-year-old female with a 26.5 mm, Grade 3, intraductal carcinoma in the left breast. SWE color map (top) shows that the colored area was heterogeneously present in the interior of the mass (Pattern 4), and the lesion had high stiffness (Emax, 204.6 kPa; Emean, 168.2 kPa; Eratio, 9.8; SD, 39.2 kPa). On pathology, the cancer showed lymphovascular invasion, positive ER and PR, negative HER2, and positive Ki-67. ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; PR, progesterone receptor; SD, standard deviation; SWE, shear wave elastography.
Figure 2.
Figure 2.
A 51-year-old female with a 4 mm, Grade 1, ductal carcinoma in situ in the left breast. B-mode ultrasound (bottom) shows that mass has irregular shape and non-circumscribed margin. SWE color map (top) shows that blue color around the lesion continues vertically on the cutaneous side (Pattern 2) and low SWE values (Emax, 33.5 kPa; Emean, 27.0 kPa; Eratio, 1.4; SD, 3.7 kPa). On pathology, the cancer showed no lymphovascular invasion, negative ER, negative PR, negative HER2, and negative Ki-67.

Similar articles

Cited by

References

    1. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403–10. doi: 10.1111/j.1365-2559.1991.tb00229.x - DOI - PubMed
    1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181–7. doi: 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H - DOI - PubMed
    1. Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 2005; 23: 7350–60. doi: 10.1200/JCO.2005.03.3845 - DOI - PubMed
    1. Tang P, Skinner KA, Hicks DG. Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready? Diagn Mol Pathol 2009; 18: 125–32. doi: 10.1097/PDM.0b013e31818d107b - DOI - PubMed
    1. Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, et al. . Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry. Breast 2012; 21: 50–7. doi: 10.1016/j.breast.2011.07.008 - DOI - PubMed

Substances